Search clinical trials for: Surufatinib and Tislelizumab _ Part 1
Total 13779 results
-
HutchmedBeiGeneActive, not recruitingSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Cancer | Colorectal Cancer | Neuroendocrine Tumors | Metastatic Solid Tumor | Anaplastic Thyroid CancerUnited States
-
Huihua XiongNot yet recruitingMetastatic Triple-negative Breast CancerChina
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchRecruitingAdvanced Hepatocellular CarcinomaTaiwan
-
Hutchison Medipharma LimitedCompletedBiliary Tract CancerChina
-
Merck Sharp & Dohme LLCTerminatedAlzheimer's Disease | Amnestic Mild Cognitive Impairment | Prodromal Alzheimer's Disease
-
Hutchison Medipharma LimitedCompleted
-
Wuhan Union Hospital, ChinaNot yet recruitingCarcinoma | Intrahepatic Cholangiocarcinoma | Gallbladder Cancer | Immunotherapy | Tislelizumab | Surufatinib | Angiogenesis Inhibitors | Antineoplastic Agents, Immunological
-
Qilu Hospital of Shandong UniversityBeiGeneRecruitingIntrahepatic CholangiocarcinomaChina
-
Zhongnan HospitalRecruitingHepatocellular Carcinoma; Targeted Therapy; Progression-free SurvivalChina
-
Janssen Research & Development, LLCCompletedHealthy | Asthma | Atopic DermatitisGermany, Belgium
-
Novartis PharmaceuticalsCompletedPrimary Biliary CholangitisUnited States, Germany, Russian Federation, Canada, United Kingdom, Poland
-
PfizerCompletedRheumatoid Arthritis | Healthy VolunteersUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Hubei Cancer HospitalRecruitingColorectal NeoplasmsChina
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Chiesi Farmaceutici S.p.A.CompletedCystic Fibrosis | Non-Cystic Fibrosis BronchiectasisBelgium
-
AstraZenecaAcerta Pharma, LLCCompletedBioavailability | B-cell Lymphoid CancerUnited States
-
Tetherex Pharmaceuticals CorporationCompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)Completed
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Daewoong Pharmaceutical Co. LTD.TerminatedMild to Moderate COVID-19Korea, Republic of
-
GlaxoSmithKlineWithdrawn
-
Huahui HealthCompleted
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...PfizerRecruitingCeliac DiseaseUnited States, Australia, New Zealand
-
UCB PharmaParexelCompleted
-
Hutchison Medipharma LimitedUnknownBiliary Tract CancerChina
-
Cellid Co., Ltd.Active, not recruitingCOVID-19 | VaccinesKorea, Republic of
-
Elpiscience Biopharma, Ltd.Active, not recruitingAdvanced Solid TumorUnited States
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
Bilthoven BiologicalsSerum Institute of India Pvt. Ltd.CompletedImmune Response to Oral Polio VaccineBangladesh
-
Janssen Cilag N.V./S.A.CompletedHealthy VolunteersUnited Kingdom
-
Bukwang PharmaceuticalActive, not recruitingParkinson Disease | DyskinesiasUnited States
-
Bausch & Lomb IncorporatedCompleted
-
Wake Forest University Health SciencesCompletedGlioma | Astrocytoma | Ependymoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | OligodendrogliomaUnited States
-
Axalbion SACompleted
-
iN Therapeutics Co., Ltd.RecruitingPain | Osteoarthritis | Chronic Pain | Neuropathic Pain | Post Herpetic NeuralgiaAustralia
-
M.D. Anderson Cancer CenterTerminatedSkin CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall Cell Lung CancerChina
-
Bilix Co.,Ltd.RecruitingIschemia-reperfusion InjuryAustralia
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruiting
-
Actimed Therapeutics LtdQuotient SciencesCompleted
-
AstraZenecaCompleted
-
M.D. Anderson Cancer CenterWithdrawnSTI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisAcute Myeloid Leukemia (AML) | Refractory T Acute Lymphoblastic LeukemiaUnited States
-
HvivoPfizerRecruiting
-
Janssen Research & Development, LLCCompletedTumor or LymphomaUnited States, France, Spain
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina
-
Domain Therapeutics SARecruitingSolid Tumor, AdultFrance, Belgium
-
Kadmon Corporation, LLCQuotient SciencesCompletedHealthy VolunteersUnited Kingdom